Back to Results
First PageMeta Content
Biotechnology / Pharmaceutical industry / Specialty drugs / Biopharmaceutical / Pharmacy


Crescendo Biologics Appoints Dr Barbara Fleck as Head of Intellectual Property Cambridge, UK: 2 February 2016 – Crescendo Biologics Limited (Crescendo), the drug discovery and developer of Humabody™ VH therapeutics,
Add to Reading List

Document Date: 2016-04-15 08:53:48


Open Document

File Size: 293,55 KB

Share Result on Facebook